2023-04-012024-03-312024-03-31false12943895LAAVIE' HEALTH CARE LTD2024-12-10falseiso4217:GBPxbrli:pure129438952023-04-01129438952024-03-31129438952023-04-012024-03-31129438952022-04-01129438952023-03-31129438952022-04-012023-03-3112943895bus:SmallEntities2023-04-012024-03-3112943895bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3112943895bus:AbridgedAccounts2023-04-012024-03-3112943895bus:PrivateLimitedCompanyLtd2023-04-012024-03-3112943895core:WithinOneYear2024-03-3112943895core:AfterOneYear2024-03-3112943895core:WithinOneYear2023-03-3112943895core:AfterOneYear2023-03-3112943895core:ShareCapital2024-03-3112943895core:SharePremium2024-03-3112943895core:RevaluationReserve2024-03-3112943895core:OtherReservesSubtotal2024-03-3112943895core:RetainedEarningsAccumulatedLosses2024-03-3112943895core:ShareCapital2023-03-3112943895core:SharePremium2023-03-3112943895core:RevaluationReserve2023-03-3112943895core:OtherReservesSubtotal2023-03-3112943895core:RetainedEarningsAccumulatedLosses2023-03-3112943895core:LandBuildings2024-03-3112943895core:PlantMachinery2024-03-3112943895core:Vehicles2024-03-3112943895core:FurnitureFittings2024-03-3112943895core:OfficeEquipment2024-03-3112943895core:NetGoodwill2024-03-3112943895core:IntangibleAssetsOtherThanGoodwill2024-03-3112943895core:ListedExchangeTraded2024-03-3112943895core:UnlistedNon-exchangeTraded2024-03-3112943895core:LandBuildings2023-03-3112943895core:PlantMachinery2023-03-3112943895core:Vehicles2023-03-3112943895core:FurnitureFittings2023-03-3112943895core:OfficeEquipment2023-03-3112943895core:NetGoodwill2023-03-3112943895core:IntangibleAssetsOtherThanGoodwill2023-03-3112943895core:ListedExchangeTraded2023-03-3112943895core:UnlistedNon-exchangeTraded2023-03-3112943895core:LandBuildings2023-04-012024-03-3112943895core:PlantMachinery2023-04-012024-03-3112943895core:Vehicles2023-04-012024-03-3112943895core:FurnitureFittings2023-04-012024-03-3112943895core:OfficeEquipment2023-04-012024-03-3112943895core:NetGoodwill2023-04-012024-03-3112943895core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112943895core:ListedExchangeTraded2023-04-012024-03-3112943895core:UnlistedNon-exchangeTraded2023-04-012024-03-3112943895core:MoreThanFiveYears2023-04-012024-03-3112943895core:Non-currentFinancialInstruments2024-03-3112943895core:Non-currentFinancialInstruments2023-03-3112943895dpl:CostSales2023-04-012024-03-3112943895dpl:DistributionCosts2023-04-012024-03-3112943895core:LandBuildings2023-04-012024-03-3112943895core:PlantMachinery2023-04-012024-03-3112943895core:Vehicles2023-04-012024-03-3112943895core:FurnitureFittings2023-04-012024-03-3112943895core:OfficeEquipment2023-04-012024-03-3112943895dpl:AdministrativeExpenses2023-04-012024-03-3112943895core:NetGoodwill2023-04-012024-03-3112943895core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112943895dpl:GroupUndertakings2023-04-012024-03-3112943895dpl:ParticipatingInterests2023-04-012024-03-3112943895dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112943895core:ListedExchangeTraded2023-04-012024-03-3112943895dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112943895core:UnlistedNon-exchangeTraded2023-04-012024-03-3112943895dpl:CostSales2022-04-012023-03-3112943895dpl:DistributionCosts2022-04-012023-03-3112943895core:LandBuildings2022-04-012023-03-3112943895core:PlantMachinery2022-04-012023-03-3112943895core:Vehicles2022-04-012023-03-3112943895core:FurnitureFittings2022-04-012023-03-3112943895core:OfficeEquipment2022-04-012023-03-3112943895dpl:AdministrativeExpenses2022-04-012023-03-3112943895core:NetGoodwill2022-04-012023-03-3112943895core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3112943895dpl:GroupUndertakings2022-04-012023-03-3112943895dpl:ParticipatingInterests2022-04-012023-03-3112943895dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3112943895core:ListedExchangeTraded2022-04-012023-03-3112943895dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3112943895core:UnlistedNon-exchangeTraded2022-04-012023-03-3112943895core:NetGoodwill2024-03-3112943895core:IntangibleAssetsOtherThanGoodwill2024-03-3112943895core:LandBuildings2024-03-3112943895core:PlantMachinery2024-03-3112943895core:Vehicles2024-03-3112943895core:FurnitureFittings2024-03-3112943895core:OfficeEquipment2024-03-3112943895core:AfterOneYear2024-03-3112943895core:WithinOneYear2024-03-3112943895core:ListedExchangeTraded2024-03-3112943895core:UnlistedNon-exchangeTraded2024-03-3112943895core:ShareCapital2024-03-3112943895core:SharePremium2024-03-3112943895core:RevaluationReserve2024-03-3112943895core:OtherReservesSubtotal2024-03-3112943895core:RetainedEarningsAccumulatedLosses2024-03-3112943895core:NetGoodwill2023-03-3112943895core:IntangibleAssetsOtherThanGoodwill2023-03-3112943895core:LandBuildings2023-03-3112943895core:PlantMachinery2023-03-3112943895core:Vehicles2023-03-3112943895core:FurnitureFittings2023-03-3112943895core:OfficeEquipment2023-03-3112943895core:AfterOneYear2023-03-3112943895core:WithinOneYear2023-03-3112943895core:ListedExchangeTraded2023-03-3112943895core:UnlistedNon-exchangeTraded2023-03-3112943895core:ShareCapital2023-03-3112943895core:SharePremium2023-03-3112943895core:RevaluationReserve2023-03-3112943895core:OtherReservesSubtotal2023-03-3112943895core:RetainedEarningsAccumulatedLosses2023-03-3112943895core:NetGoodwill2022-04-0112943895core:IntangibleAssetsOtherThanGoodwill2022-04-0112943895core:LandBuildings2022-04-0112943895core:PlantMachinery2022-04-0112943895core:Vehicles2022-04-0112943895core:FurnitureFittings2022-04-0112943895core:OfficeEquipment2022-04-0112943895core:AfterOneYear2022-04-0112943895core:WithinOneYear2022-04-0112943895core:ListedExchangeTraded2022-04-0112943895core:UnlistedNon-exchangeTraded2022-04-0112943895core:ShareCapital2022-04-0112943895core:SharePremium2022-04-0112943895core:RevaluationReserve2022-04-0112943895core:OtherReservesSubtotal2022-04-0112943895core:RetainedEarningsAccumulatedLosses2022-04-0112943895core:AfterOneYear2023-04-012024-03-3112943895core:WithinOneYear2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112943895core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112943895core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112943895core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112943895core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112943895core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112943895core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112943895core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112943895core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112943895core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112943895core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3112943895core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3112943895core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3112943895core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3112943895core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3112943895core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3112943895core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3112943895core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3112943895core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3112943895bus:Director12023-04-012024-03-3112943895bus:Director22023-04-012024-03-31

LAAVIE' HEALTH CARE LTD

Registered Number
12943895
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

LAAVIE' HEALTH CARE LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

ANTONY, Renjith, Dr
SUDHAKARAN, Simi, Dr

Registered Address

1 Wolfreton Garth
Kirk Ella
Hull
HU10 7AB

Registered Number

12943895 (England and Wales)
LAAVIE' HEALTH CARE LTD
Statement of Financial Position
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets35,5185,748
5,5185,748
Current assets
Debtors469,92652,993
Cash at bank and on hand64,26331,644
134,18984,637
Creditors amounts falling due within one year5(14,514)(9,021)
Net current assets (liabilities)119,67575,616
Total assets less current liabilities125,19381,364
Provisions for liabilities(1,379)(1,092)
Net assets123,81480,272
Capital and reserves
Called up share capital22
Profit and loss account123,81280,270
Shareholders' funds123,81480,272
The financial statements were approved and authorised for issue by the Board of Directors on 10 December 2024, and are signed on its behalf by:
ANTONY, Renjith, Dr
Director
Registered Company No. 12943895
LAAVIE' HEALTH CARE LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
Following the challenges arising as a consequence of the Covid-19 pandemic in 2020/21, more latterly the UK economy has been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company’s trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it, and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from insurance assessments carried out during the period. Revenue in respect of insurance assessments uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 237,959
Additions1,149
At 31 March 249,108
Depreciation and impairment
At 01 April 232,211
Charge for year1,379
At 31 March 243,590
Net book value
At 31 March 245,518
At 31 March 235,748
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables1,025144
Other debtors68,90152,849
Total69,92652,993
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables835485
Taxation and social security12,5867,457
Accrued liabilities and deferred income1,0931,079
Total14,5149,021
6.Related party transactions
At the year end the directors owed the company £68,901 (2023: £52,849). Interest is charged on the loan which is repayable upon demand.